Merck KGaA (ETR:MRK – Get Free Report)’s stock price traded up 0.4% during trading on Thursday . The stock traded as high as €140.30 and last traded at €140.10. Approximately 145,206 shares changed hands during mid-day trading, The stock had previously closed at €139.50.
Merck KGaA Trading Down 1.2%
The company has a debt-to-equity ratio of 40.47, a current ratio of 1.51 and a quick ratio of 0.72. The company has a market capitalization of $60.70 billion, a P/E ratio of 22.39, a price-to-earnings-growth ratio of 2.37 and a beta of 0.82. The firm has a fifty day moving average price of €133.42 and a 200-day moving average price of €123.76.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Further Reading
- Five stocks we like better than Merck KGaA
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
